Targeting Mitochondria Committees thank Supporters

Read more...

ISANH & Targeting Mitochondria Committees congratulate Pr Douglas C. Wallace, for his Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics

Pr Douglas C. Wallace, a pioneering genetics researcher who founded the field of mitochondrial genetics in humans, will receive the $500,000 Gruber Genetics Prize 2012 for Groundbreaking Contributions to Mitochondrial Genetics.

Read more...

Dr Meagan McManus, from Center for Mitochondrial and Epigenomic Medicine, will introduce Targeting Mitochondria 2012 on behalf of Pr Douglas Wallace

Pr Douglas Wallace will receive the Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics. The award ceremony will be held on November 9, and it is why he invited Dr Meagan McManus to introduce Targeting Mitochondria 2012, which will be held in Berlin on November 8-9.

Read more...

The Strategic Role of Chemistry to Target Mitochondria will be discussed by Dr Richard Hartley

Mitochondria are central to the healthy functioning of the cell, both in terms of metabolism and signaling, but also play a key role in the process of apoptosis.

Read more...

Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of MTDNA mutation

There is emerging evidence that people with successfully treated HIV infection age prematurely, leading to progressive multi-organ disease, but the reasons for this are not known.

Read more...

The abstracts book of Targeting Mitochondria 2010 & 2011 are available with special discount

The abstracts book of Targeting Mitochondria 2010 is available freely. 

Read more...

Two hot topics for Targeting Mitochondria 2012: Mito-Devices & Mito-Engineering

The Scientific Committee has selected two hot topics for this year’s meeting.

The first topic involves Mito-Devices, which are novel tools for probing mitochondrial function under physiological and pathological conditions.

Read more...

Cationic derivative of plastoquinone (visomitin), the first mitochondria-targeted medicine available in drugstores

Pr Vladimir Skulachev, from Lomonosov Moscow State University, Moscow, Russia will present his recent researches about a concept was put forward considering mitochondrial reactive oxygen species (mROS) as key intermediates of programmed aging of organism during the 3rd World Congress on Targeting Mitochondria, which will be held in Berlin on November 8-9, 2012.

Read more...